Date of Award
Master of Science (MS)
The care and management of type 2 diabetic patients has been the topic of many research studies. Diabetes is a disease that affects around 34 7 million people worldwide and continues to be a significant cause of morbidity and mortality in this population. The cardiovascular risk that has been linked to the use of thiazolidinediones, as part of the treatment regimen, is a trepidation that continues to lead healthcare providers to question its usefulness in pharmacotherapeutics. There has been much controversy over the risks versus the benefits. The case report in this paper outlines a patient with uncontrolled diabetes and a cardiac history that needs further medication management. The literature review focuses on several key issues in management of this type of patient, including the main topic: the cardiovascular risks
Cardiovascular disease is the number one complication for patients with type 2 diabetes therefore, knowing which agents are more appropriate and produce better outcomes for these patients by their health care providers is essential. If medications cause further cardiovascular complications in diabetic patients, these medications need to be identified before being prescribed to a patient. It is also pertinent the health care providers are aware of the complications that occur so they can be recognized right away if they do occur
Weidler, Amanda, "The Use of Thiazolidinediones in Type 2 Diabetic Patients" (2014). Theses and Dissertations. 4788.